N

Nutriband
D

NTRB

4.72000
USD
-0.05
(-1.05%)
Market Closed
Volume
0
EPS
-0
Div Yield
-
P/E
-6
Market Cap
52,373,993
Related Instruments
    A
    AMRS
    -0.006500
    (-10.55%)
    0.055100 USD
    B
    BYND
    -0.13500
    (-2.55%)
    5.16000 USD
    E
    ENPH
    -4.050
    (-6.37%)
    59.510 USD
    F
    FCEL
    -0.86000
    (-12.29%)
    6.14000 USD
    G
    GEVO
    -0.05500
    (-3.70%)
    1.43000 USD
    P
    PLUG
    -0.10500
    (-5.33%)
    1.86500 USD
    S
    SPWR
    0
    (0%)
    0.000000 USD
    TSLA
    TSLA
    9.69
    (3.11%)
    338.16 USD
    V
    VLGEA
    -0.435
    (-1.32%)
    32.615 USD
    More
News

Title: Nutriband

Sector: Healthcare
Industry: Biotechnology
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.